• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Percutaneous tricuspid valve implantation in failing bioprosthesis.在失效生物瓣膜中进行经皮三尖瓣植入术。
Cardiovasc Diagn Ther. 2018 Dec;8(6):765-770. doi: 10.21037/cdt.2018.09.08.
2
Percutaneous tricuspid valve implantation: two-center experience with midterm results.经皮三尖瓣植入术：两中心中期结果经验
Circ Cardiovasc Interv. 2015 Apr;8(4). doi: 10.1161/CIRCINTERVENTIONS.114.002155.
3
Percutaneous techniques for treatment of tricuspid valve dysfunction in congenital heart disease - an emerging therapy.经皮技术治疗先天性心脏病三尖瓣功能障碍——一种新兴疗法。
Expert Rev Cardiovasc Ther. 2021 Sep;19(9):817-824. doi: 10.1080/14779072.2021.1865154. Epub 2020 Dec 28.
4
Transcatheter Valve-in-Valve Implantation: Failing Tricuspid Bioprosthesis in a Patient with Ebstein’s Anomaly.经导管瓣中瓣植入术：一名患有埃布斯坦畸形患者的三尖瓣生物瓣膜功能衰竭
J Heart Valve Dis. 2017 Jan;26(1):114-117.
5
Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure.经皮导管治疗三尖瓣生物瓣功能障碍
Catheter Cardiovasc Interv. 2016 Nov 15;88(6):994-1001. doi: 10.1002/ccd.26584. Epub 2016 May 17.
6
Durability of bioprostheses for the tricuspid valve in patients with congenital heart disease.先天性心脏病患者三尖瓣生物假体的耐用性。
Eur J Cardiothorac Surg. 2016 Nov;50(5):988-993. doi: 10.1093/ejcts/ezw094. Epub 2016 Mar 22.
7
Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves: An International, Multicenter Registry Study.经导管三尖瓣瓣中瓣植入术治疗功能障碍的外科生物瓣膜：一项国际多中心注册研究
Circulation. 2016 Apr 19;133(16):1582-93. doi: 10.1161/CIRCULATIONAHA.115.019353. Epub 2016 Mar 18.
8
Edwards valve-in-valve implantation in tricuspid position.爱德华兹三尖瓣位瓣中瓣植入术
Cardiol Young. 2017 Oct;27(8):1633-1636. doi: 10.1017/S1047951117000786. Epub 2017 May 16.
9
Use of a melody pulmonary valve in transcatheter valve-in-valve replacement for tricuspid valve bioprosthesis degeneration.旋律肺动脉瓣在经导管瓣中瓣置换术治疗三尖瓣生物瓣退变中的应用。
Tex Heart Inst J. 2014 Oct 1;41(5):511-3. doi: 10.14503/THIJ-13-3544. eCollection 2014 Oct.
10
Transcatheter Tricuspid Valve Therapy.经导管三尖瓣治疗
Curr Treat Options Cardiovasc Med. 2019 May 18;21(6):26. doi: 10.1007/s11936-019-0730-7.

引用本文的文献

1
Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up.病例报告：使用新型球囊扩张式主动脉瓣经导管三尖瓣瓣中瓣植入术及1年随访
Front Cardiovasc Med. 2023 Jul 4;10:1152280. doi: 10.3389/fcvm.2023.1152280. eCollection 2023.

本文引用的文献

1
First-in-Human Implantations of the NaviGate Bioprosthesis in a Severely Dilated Tricuspid Annulus and in a Failed Tricuspid Annuloplasty Ring.NaviGate生物假体在严重扩张的三尖瓣环和失败的三尖瓣成形环中的首次人体植入。
Circ Cardiovasc Interv. 2017 Dec;10(12). doi: 10.1161/CIRCINTERVENTIONS.117.005840.
2
Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly.经导管三尖瓣瓣中瓣植入术治疗 Ebstein 畸形患者的结局。
Am J Cardiol. 2018 Jan 15;121(2):262-268. doi: 10.1016/j.amjcard.2017.10.017. Epub 2017 Oct 19.
3
Transcatheter mitral valve replacement with the NaviGate stent in a preclinical model.经导管二尖瓣置换术在临床前模型中应用 NaviGate 支架。
EuroIntervention. 2017 Dec 8;13(12):e1401-e1409. doi: 10.4244/EIJ-D-17-00210.
4
Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Björk-fontan procedure.经导管瓣膜植入术治疗改良Björk- Fontan手术后右心房至右心室管道梗阻或反流
Catheter Cardiovasc Interv. 2017 Feb 1;89(2):298-305. doi: 10.1002/ccd.26648. Epub 2016 Jul 28.
5
Durability of bioprostheses for the tricuspid valve in patients with congenital heart disease.先天性心脏病患者三尖瓣生物假体的耐用性。
Eur J Cardiothorac Surg. 2016 Nov;50(5):988-993. doi: 10.1093/ejcts/ezw094. Epub 2016 Mar 22.
6
Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves: An International, Multicenter Registry Study.经导管三尖瓣瓣中瓣植入术治疗功能障碍的外科生物瓣膜：一项国际多中心注册研究
Circulation. 2016 Apr 19;133(16):1582-93. doi: 10.1161/CIRCULATIONAHA.115.019353. Epub 2016 Mar 18.
7
Overexpansion of the SAPIEN 3 Transcatheter Heart Valve: A Feasibility Study.SAPIEN 3经导管心脏瓣膜过度扩张：一项可行性研究。
JACC Cardiovasc Interv. 2015 Dec 28;8(15):2041-2043. doi: 10.1016/j.jcin.2015.10.006.
8
Percutaneous tricuspid valve implantation: two-center experience with midterm results.经皮三尖瓣植入术：两中心中期结果经验
Circ Cardiovasc Interv. 2015 Apr;8(4). doi: 10.1161/CIRCINTERVENTIONS.114.002155.
9
Da Silva's cone repair for Ebstein's anomaly: effect on right ventricular size and function.达席尔瓦圆锥修复术治疗埃布斯坦畸形：对右心室大小和功能的影响。
Eur J Cardiothorac Surg. 2015 Aug;48(2):316-20; discussion 320-1. doi: 10.1093/ejcts/ezu472. Epub 2014 Dec 21.
10
Clinical outcome of isolated tricuspid regurgitation.孤立性三尖瓣反流的临床转归。
JACC Cardiovasc Imaging. 2014 Dec;7(12):1185-94. doi: 10.1016/j.jcmg.2014.07.018. Epub 2014 Nov 5.

在失效生物瓣膜中进行经皮三尖瓣植入术。

Percutaneous tricuspid valve implantation in failing bioprosthesis.

作者信息

Eicken Andreas, Ewert Peter

机构信息

Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Centre Munich, Technische Universität Munich, Munich, Germany.

出版信息

Cardiovasc Diagn Ther. 2018 Dec;8(6):765-770. doi: 10.21037/cdt.2018.09.08.

DOI:10.21037/cdt.2018.09.08
PMID:30740323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6331375/
Abstract

Severe tricuspid valve (TV) dysfunction in patients with congenital heart disease (CHD) is usually treated by open heart surgery in relatively young patients. If a valve plasty is not possible, a biological valve is implanted with a limited durability. Due to valve degeneration repeated valve exchanges are necessary in these patients. To expand the lifetime of a bioprosthesis in tricuspid position percutaneous TV implantation (PTVI) was introduced recently. PTVI is a promising new catheter interventional technology. The current review summarizes the indication for PTVI, describes the procedure itself and gives an outlook on medium to long-term results of this catheter intervention. PTVI in patients with severe TV dysfunction is less invasive, safe and effective, if performed by an experienced operator, and may help to reduce the total number of open-heart surgeries during a patient's life time. However, further studies with larger patient numbers and longer follow-up are needed.

摘要

先天性心脏病（CHD）患者的严重三尖瓣（TV）功能障碍通常在相对年轻的患者中通过心脏直视手术进行治疗。如果瓣膜成形术不可行，则植入生物瓣膜，但其耐久性有限。由于瓣膜退变，这些患者需要反复进行瓣膜置换。为了延长三尖瓣位生物假体的使用寿命，经皮三尖瓣植入术（PTVI）最近被引入。PTVI是一种有前景的新型导管介入技术。本综述总结了PTVI的适应证，描述了该手术本身，并对这种导管介入的中长期结果进行了展望。对于严重TV功能障碍的患者，PTVI侵入性较小、安全且有效，如果由经验丰富的操作者进行，可能有助于减少患者一生中心脏直视手术的总数。然而，需要进行更大规模患者数量和更长随访时间的进一步研究。